Gene · 4830
Papers3,561
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,561
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | Life Sci Alliance | 2022 | 35777956 | PubTator, text mining | PubMed |
| mRNAsi-related genes can effectively distinguish hepatocellular carcinoma into new molecular subtypes. | Comput Struct Biotechnol J | 2022 | 35765647 | PubTator, text mining | PubMed |
| Activated Serum Increases In Vitro Cellular Proliferation and Growth Factor Expression of Musculoskeletal Cells. | J Clin Med | 2022 | 35743510 | PubTator, text mining | PubMed |
| Delineation of Pathogenomic Insights of Breast Cancer in Young Women. | Cells | 2022 | 35741056 | PubTator, text mining | PubMed |
| Heterogeneity in Melanoma. | Cancers (Basel) | 2022 | 35740696 | PubTator, text mining | PubMed |
| LINC01088 regulates the miR-95/LATS2 pathway through the ceRNA mechanism to inhibit the growth, invasion and migration of gastric cancer cells. | Int J Immunopathol Pharmacol | 2022 | 35728587 | PubTator, text mining | PubMed |
| Compartmentalization and regulation of GTP in control of cellular phenotypes. | Trends Mol Med | 2022 | 35718686 | PubTator, text mining | PubMed |
| Genome-wide CRISPR/Cas9 transcriptional activation screen identifies a histone acetyltransferase inhibitor complex as a regulator of HIV-1 integration. | Nucleic Acids Res | 2022 | 35713529 | PubTator, text mining | PubMed |
| Lycopene in Combination With Sorafenib Additively Inhibits Tumor Metastasis in Mice Xenografted With Lewis Lung Carcinoma Cells. | Front Nutr | 2022 | 35711540 | PubTator, text mining | PubMed |
| Correlation between nm23-H_1 expression and transvaginal color Doppler ultrasound performance after radiotherapy for cervical cancer. | Transl Cancer Res | 2022 | 35706793 | PubTator, text mining | PubMed |
| The power of heteronemin in cancers. | J Biomed Sci | 2022 | 35705962 | PubTator, text mining | PubMed |
| Putative Roles of SETBP1 Dosage on the SET Oncogene to Affect Brain Development. | Front Neurosci | 2022 | 35685777 | PubTator, text mining | PubMed |
| Unveiling the Molecular Mechanisms Driving the Capsaicin-Induced Immunomodulatory Effects on PD-L1 Expression in Bladder and Renal Cancer Cell Lines. | Cancers (Basel) | 2022 | 35681623 | PubTator, text mining | PubMed |
| A Journey on Extracellular Vesicles for Matrix Metalloproteinases: A Mechanistic Perspective. | Front Cell Dev Biol | 2022 | 35669514 | PubTator, text mining | PubMed |
| Immune complexome analysis of serum samples from non-small-cell lung cancer patients identifies predictive biomarkers for nivolumab therapy. | Clin Chim Acta | 2022 | 35667476 | PubTator, text mining | PubMed |
| Systems-Level Mapping of Cancer Testis Antigen 1b/a to Sarcoma Pathways Identifies Activated Ran Binding-2 E3 SUMO-Protein Ligase and Transducin-Like Enhancer Protein 1. | Front Genet | 2022 | 35664317 | PubTator, text mining | PubMed |
| Editor's Note: Characterization of a Novel Mechanism of Genomic Instability Involving the SEI1/SET/NM23H1 Pathway in Esophageal Cancers. | Cancer Res | 2022 | 35661200 | PubTator, text mining | PubMed |
| Identification of Significant Secreted or Membrane-Located Proteins in Laryngeal Squamous Cell Carcinoma. | J Immunol Res | 2022 | 35655921 | PubTator, text mining | PubMed |
| A journey from phosphotyrosine to phosphohistidine and beyond. | Mol Cell | 2022 | 35654043 | PubTator, text mining | PubMed |
| Research Advances on Anti-Cancer Natural Products. | Front Oncol | 2022 | 35646647 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4830/papers?page=19